| Title |
Task force on management and prevention of Acinetobacter baumannii infections in the ICU
|
|---|---|
| Published in |
Intensive Care Medicine, October 2015
|
| DOI | 10.1007/s00134-015-4079-4 |
| Pubmed ID | |
| Authors |
José Garnacho-Montero, George Dimopoulos, Garyphallia Poulakou, Murat Akova, José Miguel Cisneros, Jan De Waele, Nicola Petrosillo, Harald Seifert, Jean François Timsit, Jordi Vila, Jean-Ralph Zahar, Matteo Bassetti |
| Abstract |
Acinetobacter baumannii constitutes a dreadful problem in many ICUs worldwide. The very limited therapeutic options available for these organisms are a matter of great concern. No specific guidelines exist addressing the prevention and management of A. baumannii infections in the critical care setting. Clinical microbiologists, infectious disease specialists and intensive care physicians were invited by the Chair of the Infection Section of the ESICM to participate in a multidisciplinary expert panel. After the selection of clinically relevant questions, this document provides recommendations about the use of microbiological techniques for identification of A. baumannii in clinical laboratories, antibiotic therapy for severe infections and recommendations to control this pathogen in outbreaks and endemic situations. Evidence supporting each statement was graded according to the European Society of Clinical Microbiology and Infection Diseases (ESCMID) grading system. Empirical coverage of A. baumannii is recommended in severe infections (severe sepsis or septic shock) occurring during an A. baumannii outbreak, in an endemic setting, or in a previously colonized patient. For these cases, a polymyxin is suggested as part of the empirical treatment in cases of a high suspicion of a carbapenem-resistant (CR) A. baumannii strain. An institutional program including staff education, promotion of hand hygiene, strict contact and isolation precautions, environmental cleaning, targeted active surveillance, and antimicrobial stewardship should be instituted and maintained to combat outbreaks and endemic situations. Specific recommendations about prevention and management of A. baumannii infections in the ICU were elaborated by this multidisciplinary panel. The paucity of randomized controlled trials is noteworthy, so these recommendations are mainly based on observational studies and pharmacodynamics modeling. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 20% |
| United States | 1 | 20% |
| Belgium | 1 | 20% |
| Unknown | 2 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Scientists | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Italy | 1 | <1% |
| Unknown | 184 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 26 | 14% |
| Other | 23 | 12% |
| Student > Master | 19 | 10% |
| Student > Bachelor | 15 | 8% |
| Researcher | 14 | 8% |
| Other | 38 | 20% |
| Unknown | 51 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 63 | 34% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 7% |
| Immunology and Microbiology | 10 | 5% |
| Nursing and Health Professions | 8 | 4% |
| Agricultural and Biological Sciences | 5 | 3% |
| Other | 27 | 15% |
| Unknown | 60 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2017.
All research outputs
#2,880,539
of 22,829,683 outputs
Outputs from Intensive Care Medicine
#1,814
of 4,986 outputs
Outputs of similar age
#41,384
of 277,499 outputs
Outputs of similar age from Intensive Care Medicine
#11
of 63 outputs
Altmetric has tracked 22,829,683 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,986 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.1. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,499 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.